By printing and/or reading this article, you agree that you accept all terms and conditions of use, as specified online.

Breastfeeding and Menopause Can Affect Breast Cancer

In the news...(August 31, 2008) - Factors such as age at menopause as well as a woman's breastfeeding practices can influence her risk of developing certain types of breast cancer. (Read about "Menopause" "Breastfeeding" "Breast Cancer") That was the conclusion of a new study published in CANCER, a journal of the American Cancer Society. The study's results suggest that there are distinct and separate hormonal risk factors associated with different subtypes of breast cancer.

Differences among breast cancer subtypes have been well-described, but researchers have limited data on how the various subtypes arise and which individuals are at greatest risk. Having this information could help physicians identify which women are more likely to develop certain subtypes of breast cancer, which respond differently to different anti-cancer therapies and have very different survival rates.

Researchers conducted a study to better understand the specific risk factors for the subtypes of breast cancer, which are classified by expression of the estrogen receptor, the progesterone receptor and the HER2 receptor. Some breast cancer types express one or more of these proteins on their cell surface, while others express none. The research team suspected that reproductive or hormonal factors may play a significant role in a woman's risk of developing different subtypes because these cell receptors are influenced by endogenous sex hormones.

The investigators found that reproductive risk factors varied considerably by breast cancer subtype. For example, early age at menarche was associated with risk of HER2-overexpressing disease but not with any other subtype. Breastfeeding for 6 months or longer was associated with a lower risk of luminal cancer as well as triple-negative cancer, a type that can be particularly aggressive and difficult to treat. Both late age at menopause and use of estrogen plus progestin hormone therapy were associated with an increased risk of luminal disease. Finally, no differences in risks associated with number of children or the age when a woman first gave birth were observed by subtype.

Note: Statements and conclusions of study authors that are published here are solely those of the study authors and do not necessarily reflect this hospital's policy or position. This hospital makes no representation or warranty as to their accuracy or reliability.

All Concept Communications material is provided for information only and is neither advice nor a substitute for proper medical care. Consult a qualified healthcare professional who understands your particular history for individual concerns.

© Concept Communications Media Group LLC

Online health topics reviewed/modified in 2008 | Terms of Use/Privacy Policy

By printing and/or reading this article, you agree that you accept all terms and conditions of use, as specified online.